Announcement

All content
All content
CISION PR Newswire
Announcement

Mira Murati, CTO of OpenAI, Joins Unlearn.AI's Board of Directors

Read more
CISION PR Newswire
Announcement

Mira Murati, CTO of OpenAI, Joins Unlearn.AI's Board of Directors

Read more
Business Wire
Announcement

Unlearn Appoints Alex Lang, Ph.D. as Vice President, Technology

Read more
Business Wire
Announcement

Unlearn Appoints Alex Lang, Ph.D. as Vice President, Technology

Read more
Business Wire
Announcement

European Medicines Agency Qualifies Unlearn’s AI-powered Method for Running Smaller, Faster Clinical Trials

Read more
Business Wire
Announcement

European Medicines Agency Qualifies Unlearn’s AI-powered Method for Running Smaller, Faster Clinical Trials

Read more
Business Wire
Announcement

Unlearn Closes $50 Million Series B Funding to Advance the Use of Its Machine Learning-Powered TwinRCTs™ in Clinical Trials

Read more
Business Wire
Announcement

Unlearn Closes $50 Million Series B Funding to Advance the Use of Its Machine Learning-Powered TwinRCTs™ in Clinical Trials

Read more
Business Wire
Announcement

Unlearn Receives Draft Qualification Opinion from European Medicines Agency for Using the PROCOVA™ Framework to Implement TwinRCTs™

Read more
Business Wire
Announcement

Unlearn Receives Draft Qualification Opinion from European Medicines Agency for Using the PROCOVA™ Framework to Implement TwinRCTs™

Read more
Business Wire
Announcement

Unlearn Signs Multi-Year Collaboration with Merck KGaA, Darmstadt, Germany to Accelerate Immunology Trials using Twintelligent RCTs™

Read more
Business Wire
Announcement

Unlearn Signs Multi-Year Collaboration with Merck KGaA, Darmstadt, Germany to Accelerate Immunology Trials using Twintelligent RCTs™

Read more
Business Wire
Announcement

Unlearn.AI Announces Results Generated from First-of-its-Kind Machine Learning Platform to Accelerate Alzheimer’s Drug Development

Read more
Business Wire
Announcement

Unlearn.AI Announces Results Generated from First-of-its-Kind Machine Learning Platform to Accelerate Alzheimer’s Drug Development

Read more
Business Wire
Announcement

Unlearn Appoints Arman Sabbaghi, Ph.D. as Head of Biostatistics Research

Read more
Business Wire
Announcement

Unlearn Appoints Arman Sabbaghi, Ph.D. as Head of Biostatistics Research

Read more
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.